SCHEDULE: AIGH Capital Management Discloses 5.9% Stake in Grace Therapeutics

AIGH Capital Management LLC and Orin Hirschman have disclosed a 5.9% beneficial ownership stake in Grace Therapeutics, Inc., holding 907,217 common shares.

Summary

• Orin Hirschman and AIGH Capital Management LLC are the reporting persons for this beneficial ownership disclosure.
• The issuer is Grace Therapeutics, Inc., with its principal executive offices at 103 Carnegie Center, Suite 300, Princeton, NJ, 08540.
• The class of securities is Common Stock, identified by CUSIP Number 00439U104.
• The reporting persons beneficially own an aggregate of 907,217 shares of Common Stock.
• This ownership represents 5.9% of the class of Grace Therapeutics, Inc. Common Stock.
• The reporting persons hold sole voting power and sole dispositive power over all 907,217 shares.
• The reported amount excludes 824,742 common shares issuable upon the exercise of warrants that are not currently exercisable due to beneficial ownership limitations.
• The event requiring this filing occurred on December 31, 2025.
• This is an Amendment No. 3 to the Schedule 13G filing.

Sentiment

Score: 5

Explanation: The filing is a standard regulatory disclosure of beneficial ownership and does not contain information that would inherently suggest a positive or negative sentiment regarding the issuer's performance or prospects. It is a factual update on an existing passive investment.

Positives

• A significant institutional investor, AIGH Capital Management LLC, and its managing member, Orin Hirschman, maintain a substantial stake in Grace Therapeutics, Inc., indicating continued interest.
• The filing explicitly states the investment is passive, acquired and held in the ordinary course of business, and not for the purpose of changing or influencing control of the issuer, which can signal a stable, long-term holding.

Negatives

• No specific negatives about Grace Therapeutics, Inc. are disclosed in this beneficial ownership filing.

Risks

• No specific risks related to Grace Therapeutics, Inc. are mentioned in this beneficial ownership filing.

Future Outlook

NA

Management Comments

• Orin Hirschman, as a reporting person and Managing Member of AIGH Capital Management LLC, certified that the securities were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer.

Industry Context

This filing reflects a routine disclosure of significant passive ownership by an investment advisor, common in the financial industry for transparency regarding institutional holdings in public companies. It provides insight into the ownership structure of Grace Therapeutics, Inc. by a notable investment entity.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional holder's updated stake, potentially signaling continued confidence or at least a passive investment interest in the company.
• Management: Awareness of a significant passive shareholder and their updated ownership percentage.

Key Dates

Recommendation

This Schedule 13G Amendment No. 3 filing indicates a passive beneficial ownership stake by AIGH Capital Management LLC and Orin Hirschman, holding 5.9% of Grace Therapeutics, Inc. common stock. The filing explicitly states the securities were acquired in the ordinary course of business and not for the purpose of changing or influencing control. As such, it does not provide new fundamental information about the company's operational performance, strategic direction, or valuation that would warrant a change in investment recommendation. It primarily serves as a transparency disclosure of a significant, but passive, institutional holding. Therefore, a 'hold' recommendation is appropriate, maintaining existing positions based on prior analysis of the company's fundamentals.

Keywords

Grace Therapeutics, AIGH Capital Management, Orin Hirschman, beneficial ownership, Schedule 13G, common stock, institutional investor, passive investment